| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 1e-08 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 3e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 5e-06 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.14 | 3e-05 |